Total Payments
$382,611
2024 Payments
$53,397
Companies
36
Transactions
436
Medicare Patients
3,924
Medicare Billing
$504,098
Payment Breakdown by Category
Other$210,884 (55.1%)
Consulting$126,350 (33.0%)
Travel$28,762 (7.5%)
Food & Beverage$10,057 (2.6%)
Education$4,132 (1.1%)
Research$2,427 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $174,119 | 79 | 45.5% |
| Consulting Fee | $126,350 | 47 | 33.0% |
| Honoraria | $32,940 | 23 | 8.6% |
| Travel and Lodging | $28,762 | 76 | 7.5% |
| Food and Beverage | $10,057 | 191 | 2.6% |
| Education | $4,132 | 4 | 1.1% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $3,825 | 6 | 1.0% |
| Unspecified | $2,427 | 10 | 0.6% |
Payments by Type
General
$380,185
426 transactions
Research
$2,427
10 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $85,376 | 90 | $0 (2024) |
| PROGENICS PHARMACEUTICALS, INC. | $65,803 | 48 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $43,393 | 52 | $0 (2023) |
| Blue Earth Diagnostics Limited | $40,025 | 50 | $0 (2024) |
| Astellas Pharma US Inc | $33,695 | 25 | $0 (2024) |
| PFIZER INC. | $27,195 | 28 | $0 (2024) |
| Astellas Pharma Global Development | $26,384 | 17 | $0 (2024) |
| Myovant Sciences Inc. | $20,346 | 23 | $0 (2022) |
| Sumitomo Pharma America, Inc. | $12,800 | 14 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $5,196 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $53,397 | 55 | Janssen Biotech, Inc. ($17,282) |
| 2023 | $87,752 | 94 | Bayer Healthcare Pharmaceuticals Inc. ($19,012) |
| 2022 | $97,563 | 98 | Progenics Pharmaceuticals, Inc. ($42,366) |
| 2021 | $68,346 | 48 | Janssen Biotech, Inc. ($19,012) |
| 2020 | $38,128 | 31 | Janssen Biotech, Inc. ($10,763) |
| 2019 | $24,931 | 57 | Astellas Pharma US Inc ($7,364) |
| 2018 | $11,429 | 39 | Blue Earth Diagnostics Limited ($7,338) |
| 2017 | $1,067 | 14 | Endocare, Inc. ($853.59) |
All Payment Transactions
436 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,100.00 | General |
| Category: Oncology | ||||||
| 12/04/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: OS | ||||||
| 11/18/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: OS | ||||||
| 11/17/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $7.11 | General |
| Category: OS | ||||||
| 11/15/2024 | Janssen Scientific Affairs, LLC | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: Oncology | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Travel and Lodging | Cash or cash equivalent | $62.12 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,125.00 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Travel and Lodging | In-kind items and services | $1,644.06 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $129.50 | General |
| Category: HORMONE THERAPY | ||||||
| 11/04/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $71.78 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $550.00 | General |
| Category: Oncology | ||||||
| 10/19/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $134.38 | General |
| Category: OS | ||||||
| 10/17/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,575.00 | General |
| Category: Oncology | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $28.15 | General |
| Category: Oncology | ||||||
| 10/15/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $124.54 | General |
| Category: Oncology | ||||||
| 10/11/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Consulting Fee | Cash or cash equivalent | $5,185.00 | General |
| Category: Oncology | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $2,100.00 | General |
| 10/08/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Travel and Lodging | In-kind items and services | $123.77 | General |
| Category: Oncology | ||||||
| 10/04/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Travel and Lodging | Cash or cash equivalent | $87.00 | General |
| Category: Oncology | ||||||
| 10/04/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Travel and Lodging | Cash or cash equivalent | $50.21 | General |
| Category: Oncology | ||||||
| 10/04/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Oncology | ||||||
| 09/25/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: Oncology | ||||||
| 08/26/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $87.23 | General |
| Category: Diagnostic Imaging | ||||||
| 08/13/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $142.70 | General |
| Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Randomized Study of Enzalutamide in Patients With Localized Prostate Cancer Undergoing Active Surveillance (ENACT) | Astellas Pharma Global Development | $2,427 | 10 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 1,197 | 1,480 | $1.3M | $156,176 |
| 2022 | 19 | 1,185 | 1,531 | $1.2M | $172,668 |
| 2021 | 18 | 883 | 986 | $660,135 | $118,079 |
| 2020 | 18 | 659 | 727 | $282,702 | $57,175 |
Total Patients
3,924
Total Services
4,724
Medicare Billing
$504,098
Procedure Codes
74
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 23 | 170 | $461,040 | $22,313 | 4.8% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 107 | 108 | $146,556 | $20,192 | 13.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 93 | 113 | $49,042 | $14,731 | 30.0% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2023 | 15 | 15 | $136,755 | $14,625 | 10.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 149 | 161 | $52,003 | $14,352 | 27.6% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 185 | 227 | $39,725 | $14,170 | 35.7% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 121 | 140 | $35,000 | $12,240 | 35.0% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 98 | 102 | $72,012 | $11,436 | 15.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 36 | 36 | $22,500 | $6,529 | 29.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 58 | 58 | $29,376 | $5,862 | 20.0% |
| 76377 | 3d radiographic procedure with computerized image postprocessing | Office | 2023 | 87 | 88 | $82,016 | $5,473 | 6.7% |
| 38571 | Removal of lymph nodes of both sides of pelvis using an endoscope | Facility | 2023 | 14 | 14 | $59,262 | $3,969 | 6.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 16 | 17 | $19,771 | $3,148 | 15.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 49 | $10,731 | $2,948 | 27.5% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 13 | 13 | $17,641 | $1,306 | 7.4% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 23 | 46 | $10,902 | $1,292 | 11.9% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 15 | 15 | $13,395 | $727.97 | 5.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 57 | 67 | $1,340 | $562.80 | 42.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 38 | 41 | $9,430 | $297.99 | 3.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2022 | 31 | 195 | $455,226 | $26,546 | 5.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 122 | 155 | $67,270 | $21,576 | 32.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 159 | 212 | $53,000 | $20,632 | 38.9% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2022 | 15 | 15 | $136,755 | $18,636 | 13.6% |
| 55700 | Biopsy of prostate gland | Office | 2022 | 92 | 92 | $124,844 | $18,208 | 14.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 151 | 168 | $54,264 | $14,371 | 26.5% |
About Ashley Ross
Ashley Ross is a Urology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1891840641.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ashley Ross has received a total of $382,611 in payments from pharmaceutical and medical device companies, with $53,397 received in 2024. These payments were reported across 436 transactions from 36 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($174,119).
As a Medicare-enrolled provider, Ross has provided services to 3,924 Medicare beneficiaries, totaling 4,724 services with total Medicare billing of $504,098. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Chicago, IL
- Active Since 01/24/2007
- Last Updated 07/01/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1891840641
Products in Payments
- ERLEADA (Drug) $81,444
- PYLARIFY (Drug) $65,803
- ORGOVYX (Drug) $45,790
- Xtandi (Drug) $30,808
- Nubeqa (Drug) $26,409
- Axumin (Drug) $23,389
- XTANDI (Drug) $15,166
- POSLUMA (Drug) $13,448
- Erleada (Drug) $8,293
- Xofigo (Drug) $6,544
- Da Vinci Surgical System (Device) $5,169
- LUTATHERA (Drug) $2,400
- LUPRON DEPOT (Drug) $2,143
- TALZENNA (Drug) $2,000
- PROVENGE (Drug) $986.48
- Endocare Cryocare System (Medical Supply) $853.59
- Non-Covered $580.00
- NANOKNIFE (Device) $171.87
- ELIGARD (Drug) $129.79
- GENERAL THERAPIES (Device) $119.09
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Chicago
Gary Steinberg, M D, M D
Urology — Payments: $586,688
Urology $586,688
Simone Crivellaro, Md, MD
Urology — Payments: $459,193
Urology $459,193
Brian Helfand, M.d./Ph.d, M.D./PH.D
Urology — Payments: $380,392
Urology $380,392
Amy Krambeck, M.d, M.D
Urology — Payments: $350,930
Urology $350,930
Dr. Kevin Zorn, M.d, M.D
Urology — Payments: $302,808
Urology $302,808
Laurence Levine, Md, MD
Urology — Payments: $287,103
Urology $287,103